The challenge and promise of anti-epileptic therapy development in animal models
Year: 2014
Type: review
Source: The Lancet Neurology
Institutions: University of Ferrara, Children's Hospital Colorado, University of Colorado Anschutz, University of California, Los Angeles, Albert Einstein College of Medicine, University of Pennsylvania, The Royal Melbourne Hospital, The University of Melbourne, University of Eastern Finland, Kuopio University Hospital, University of Utah, NYU Langone Health, New York University
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: U.S. Department of Defense, Autism Speaks, CURE Childhood Cancer, GlaxoSmithKline, Novartis, AES Corporation, Royal Melbourne Hospital Neuroscience Foundation, European Commission, European Science Foundation, Academy of Finland, Ministero dell’Istruzione, dell’Università e della Ricerca, Sigrid Juséliuksen Säätiö, Epilepsiatutkimussäätiö, National Institutes of Health, National Health and Medical Research Council, National Institute of Neurological Disorders and Stroke, Janssen Pharmaceuticals, FP7 Health
Awards: Clinical Research Program for the Partial Epilepsies, G1068090787, Calcium Signaling in a Model of Temporal Lobe Epilepsy, G1695547610, Consequences of Prolonged Febrile Seizures in Childhood, G2142641812, G2581429708, Prototype Manufacture of Next Generation Minimally-Invasive Brain Computer Interface, Early Randomized Surgical Epilepsy Trial, Whole Genome Pharmacogenomics Study of Susceptibility of Birth Defects in Children born to mothers taking Anti-Epileptic Drugs, IN VIVO STUDIES OF THE EPILEPTIC HIPPOCAMPUS, THE EFFECT OF STRESS AND ENVIRONMENTAL ENRICHMENT ON DISEASE PROGRESSION IN MESIAL TEMPORAL LOBE EPILEPSY, Impact of Initial Therapy and Response on Long Term Outcome in Children with CAE, Age Related Seizure Suppression, GABA (A) Receptors in Developmental Epileptogenesis, In Vivo Studies of the Epileptic Hippocampus, JAK/STAT INHIBITION TO PREVENT POST TRAMATIC EPILEPTOGENESIS, The Epileptogenic Effect of Perinatal Hypoxia, The Epileptogenic Effect of Perinatal Hypoxia, Fisiologia e fisiopatologia di BDNF: verso lo sviluppo di nuove strategie terapeutiche per alcune delle principali malattie neuro-psichiatriche, Early Life Seizures Disrupt Critical Period Plasticity, G50628176, Age related seizure suppression, G5882848380, Screening for new therapies for refractory infantile spasms, Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD), G6517766667, The NKCC1 inhibitor bumetanide as a novel therapy in TSC, G6757901252, Development of novel JAK/STAT inhibitors for Epilepsy prevention and treatment, The Epilepsy Bioinformatics Study (EpiBioS), Consequences of Prolonged Febrile Seizures in Childhood, A Novel Mouse Model of Temporal Lobe Epilepsy, G8579974388, Preventing and treating epilepsy, brain degeneration and psychiatric disease following a brain injury., G8818542328, New antiepileptic drugs that only act during seizure, G9000330775, Javits Award Final Three Years
OpenAlex ID: W2138234506